# 4D Molecular Therapeutics, Inc.: Form S-1, filed Nov 17, 2020

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: S-1
- Filed: 2020-11-17
- Accepted by EDGAR: Nov 17, 2020, 22:25 ET
- Period: not reported
- Accession: 0001193125-20-296146
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000119312520296146/d69563ds1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000119312520296146/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000119312520296146/d69563ds1.htm

Filed Nov 17, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-296146. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.